Chenguang Biotech Group (300138) — Free Cash Flow Generation Index

Latest as of September 2025: 0.93x

Chenguang Biotech Group (300138) has a Free Cash Flow Generation Index of 0.93x as of September 2025. Free cash flow of CN¥487.33 Million represents 1% of operating cash flow (CN¥524.96 Million). Read total liabilities of Chenguang Biotech Group for a breakdown of total debt and financial obligations.

FCF Generation Index

0.93x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥487.33 Million
CNY

Operating Cash Flow

CN¥524.96 Million
CNY

Capital Expenditures

CN¥37.63 Million
CNY

Chenguang Biotech Group Free Cash Flow Generation Index (2008–2022)

Historical FCF Generation Index trend for Chenguang Biotech Group across 7 annual periods. Explore reinvestment intensity of Chenguang Biotech Group to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Chenguang Biotech Group (2008–2022)

Year-by-year Free Cash Flow Generation Index for Chenguang Biotech Group. For the full company profile including market capitalisation, see Chenguang Biotech Group stock valuation.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2022 0.76x CN¥558.78 Million CN¥734.81 Million CN¥176.03 Million ▲ +122.4%
2021 -3.39x CN¥-216.92 Million CN¥63.90 Million CN¥280.82 Million ▼ -2042.1%
2020 0.17x CN¥92.54 Million CN¥529.41 Million CN¥436.88 Million ▼ -79.8%
2014 0.87x CN¥236.33 Million CN¥272.96 Million CN¥36.62 Million ▲ +171.5%
2011 -1.21x CN¥-99.54 Million CN¥82.18 Million CN¥181.72 Million ▲ +16.8%
2009 -1.46x CN¥-39.67 Million CN¥27.23 Million CN¥66.90 Million ▲ +22.3%
2008 -1.87x CN¥-16.99 Million CN¥9.06 Million CN¥26.05 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).